Lipid Nanoparticle (LNP) Services
Advanced Delivery Solutions for RNA Therapeutics
Lipid nanoparticles (LNPs) are critical delivery vehicles in the development of RNA-based therapeutics, ensuring the safe and effective transport of nucleic acids into target cells. Recipharm Advanced Bio offers integrated LNP services designed to accelerate your xRNA project from early clinical stages through commercialization. Our comprehensive approach combines flexibility, innovation, and quality to meet each project’s unique needs.
LNP Formulation & Manufacturing Capabilities
Our state-of-the-art facilities are equipped to handle the complexities of LNP formulation and manufacturing, providing scalable solutions tailored to your project’s requirements.
Capable of producing LNP formulations ranging from 1 to 100+ grams, accommodating various project scales
Utilizing adaptable systems to ensure efficiency and reduce cross-contamination risks
Expertise with multiple mixing systems to accommodate numerous formulation processes, including jet, microfluidic, and tee-mixing
Tangential Flow Filtration (TFF) capabilities support outstanding product quality, scalability, and precise formulation control
Our facilities are meticulously designed to safely and efficiently handle and store flammable solvents essential for LNP manufacturing. This infrastructure supports our commitment to safety and quality throughout the production process.
Integrated LNP Analytical Testing & Quality Assurance
Ensuring the integrity and efficacy of your LNP formulations is paramount. Our comprehensive analytical testing capabilities are designed to meet rigorous quality standards.
LNP analytical testing services
Implementing standard qualification strategies tailored to the development stage of your product
Conducting complete stability studies under ICH conditions to assess product shelf-life and performance
Evaluating the impact of temperature variations on LNP integrity and functionality
Performing comprehensive analytical tests on-site to ensure rapid and accurate results
Our collaborative approach ensures efficient project management, and we provide expert guidance and support throughout the lifecycle of your RNA project.
Innovation Spotlight
The world’s first continuous and integrated nucleic acid manufacturing platform
Recipharm Advanced Bio’s xRNA manufacturing platform is the future of xRNA production. Grant funding by the FDA’s Center for Biologics Evaluation and Research (CBER) Advanced Technology Program and in partnership with MIT, Recipharm Advanced Bio has assembled AI-enabled production, digital control, and advanced process analytical technologies (PAT) to shorten timelines and optimize xRNA product quality.
Learn More
Seamless Integration with ATMP Sterile Fill-Finish Services
As part of our end-to-end service offering, we provide Advanced Therapy Medicinal Products (ATMP) fill and finish services to ensure the highest quality standards are met in the final product.
ATMP Fill-Finish Capabilities
State-of-the-art aseptic processing environments to maintain product integrity
Customized packaging options to meet specific product requirements
Adherence to global regulatory standards to facilitate product approval and market entry
Discover how our fill and finish services can seamlessly integrate into your LNP project, ensuring a smooth transition from production to final product.
Learn MoreLipid Nanoparticle Resources
Advancing Your Program Together
Your program isn’t just another project—it’s a breakthrough in the making. At Recipharm Advanced Bio, we bring deep scientific expertise, innovative thinking, and a problem-solving mindset to every partnership. Whether scaling a complex process, navigating regulatory pathways, or optimizing for commercial success, we’re here to collaborate, adapt, and deliver with excellence.
Let’s push the boundaries of possibility together and bring transformative therapies to patients faster.